Identification of a novel inhibitor of SARS-CoV-2 3CL-PRO through virtual screening and molecular dynamics simulation

AK Bepari, HM Reza - PeerJ, 2021 - peerj.com
Background The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has ravaged lives
across the globe since December 2019, and new cases are still on the rise. Peoples' …

Exploring whether iron sequestration within the CNS of patients with Alzheimer's disease causes a functional iron deficiency that advances neurodegeneration

SM LeVine, S Tsau, S Gunewardena - Brain Sciences, 2023 - mdpi.com
The involvement of iron in the pathogenesis of Alzheimer's disease (AD) may be
multifaceted. Besides potentially inducing oxidative damage, the bioavailability of iron may …

Tetrahydrobiopterin (BH4) treatment stabilizes tyrosine hydroxylase: Rescue of tyrosine hydroxylase deficiency phenotypes in human neurons and in a knock‐in …

K Jung‐kc, A Tristán‐Noguero… - Journal of Inherited …, 2024 - Wiley Online Library
Proteostatic regulation of tyrosine hydroxylase (TH), the rate‐limiting enzyme in dopamine
biosynthesis, is crucial for maintaining proper brain neurotransmitter homeostasis. Variants …

Computational methods to assist in the discovery of pharmacological chaperones for rare diseases

B Scafuri, A Verdino, N D'Arminio… - Briefings in …, 2022 - academic.oup.com
Pharmacological chaperones are chemical compounds able to bind proteins and stabilize
them against denaturation and following degradation. Some pharmacological chaperones …

Personalized medicine to improve treatment of dopa-responsive dystonia—a focus on tyrosine hydroxylase deficiency

G Nygaard, PD Szigetvari, AK Grindheim… - Journal of Personalized …, 2021 - mdpi.com
Dopa-responsive dystonia (DRD) is a rare movement disorder associated with defective
dopamine synthesis. This impairment may be due to the fact of a deficiency in GTP …

The quaternary structure of human tyrosine hydroxylase: effects of dystonia‐associated missense variants on oligomeric state and enzyme activity

PD Szigetvari, G Muruganandam… - Journal of …, 2019 - Wiley Online Library
Tyrosine hydroxylase (TH) is a multi‐domain, homo‐oligomeric enzyme that catalyses the
rate‐limiting step of catecholamine neurotransmitter biosynthesis. Missense variants of …

Brain catecholamine depletion and motor impairment in a Th knock-in mouse with type B tyrosine hydroxylase deficiency

G Korner, D Noain, M Ying, M Hole, MI Flydal… - Brain, 2015 - academic.oup.com
Tyrosine hydroxylase catalyses the hydroxylation of L-tyrosine to l-DOPA, the rate-limiting
step in the synthesis of catecholamines. Mutations in the TH gene encoding tyrosine …

[HTML][HTML] Functional and structural impact of 10 ACADM missense mutations on human medium chain acyl-Coa dehydrogenase

CA Madeira, C Anselmo, JM Costa, CA Bonito… - … et Biophysica Acta (BBA …, 2023 - Elsevier
Medium chain acyl-CoA dehydrogenase (MCAD) deficiency (MCADD) is associated with
ACADM gene mutations, leading to an impaired function and/or structure of MCAD …

Levalbuterol lowers the feedback inhibition by dopamine and delays misfolding and aggregation in tyrosine hydroxylase

MI Flydal, TA Kråkenes, MDS Tai, MPA Tran, K Teigen… - Biochimie, 2021 - Elsevier
Tyrosine hydroxylase (TH) catalyses the (6 R)-L-erythro-5, 6, 7, 8-tetrahydrobiopterin (BH4)-
dependent conversion of L-tyrosine to L-3, 4-dihydroxyphenylalanine (L-Dopa), which is the …

EU-OPENSCREEN: a novel collaborative approach to facilitate chemical biology

P Brennecke, D Rasina, O Aubi… - … Life Sciences R&D, 2019 - journals.sagepub.com
Compound screening in biological assays and subsequent optimization of hits is
indispensable for the development of new molecular research tools and drug candidates. To …